Recent clinical trials have examined the use of GLP-1s in resolving many other issues commonly related to obesity, including heart disease, sleep apnea and kidney disease
Korkushko OV, Khavinson VKh, Shatilo VB, Magdich LV
They have the expertise to explain key details, like proper injection techniques, side effects, and new indications, to patients and healthcare providers
The Bridge Program is a temporary demonstration project running from July 1, 2026, through December 2027
Key Differences Summary# Conclusion# Cortistatin and DSIP represent two fundamentally different approaches to direct sleep modulation
Figure 6 and Table 3 summarize potential pathways which BBR exerted protective effects in the treatment of diabetic complications